US FDA eases warnings for Roche's Rocephin
This article was originally published in Scrip
Executive Summary
US label warnings for the cephalosporin antibiotic ceftriaxone (Roche's Rocephin and generics) have been eased to reflect new FDA recommendations about use with calcium-containing products.